Brain Tumor Reports
54

Volume 17 Number 1
January 2015


Home > Publications > Brain Tumor Reports > Volume 17, Year 2015 > Number 1, January*


CONTENTS



ANAPLASTIC ASTROCYTOMA
BRAIN TUMORS
GLIOBLASTOMA
GLIOMAS
MENINGIOMA
OLIGODENDROGLIOMA





ANAPLASTIC ASTROCYTOMA



Chamberlain MC.
Salvage therapy with lomustine for temozolomide refractory recurrent anaplastic astrocytoma: a retrospective study.
J Neurooncol. 2015 Jan 7. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





BRAIN TUMORS



Swartling FJ, Čančer M, Frantz A, Weishaupt H, Persson AI.
Deregulated proliferation and differentiation in brain tumors.
Cell Tissue Res. 2015 Jan;359(1):225-54. doi: 10.1007/s00441-014-2046-y. Epub 2014 Nov 23.
Source | Abstract | Full text | Similar articles





GLIOBLASTOMA



Chheda MG, Wen PY, Hochberg FH, Chi AS, Drappatz J, Eichler AF, Yang D, Beroukhim R, Norden AD, Gerstner ER, Betensky RA, Batchelor TT.
Vandetanib plus sirolimus in adults with recurrent glioblastoma: results of a phase I and dose expansion cohort study.
J Neurooncol. 2015 Feb;121(3):627-34. doi: 10.1007/s11060-014-1680-2. Epub 2014 Dec 13.
Source | Abstract | Full text | Similar articles




Di Stefano AL, Labussiere M, Lombardi G, Eoli M, Bianchessi D, Pasqualetti F, Farina P, Cuzzubbo S, Gallego-Perez-Larraya J, Boisselier B, Ducray F, Cheneau C, Moglia A, Finocchiaro G, Marie Y, Rahimian A, Hoang-Xuan K, Delattre JY, Mokhtari K, Sanson M.
VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab.
J Neurooncol. 2015 Feb;121(3):499-504. doi: 10.1007/s11060-014-1677-x. Epub 2014 Dec 7.
Source | Abstract | Full text | Similar articles




Duerinck J, Clement PM, Bouttens F, Andre C, Neyns B, Staelens Y, Van Fraeyenhove F, Baurain JF, Luce S, D'hondt L, Joosens E, Specenier P, Verschaeve V, Filleul B, Vroman P, Stragier B, Rogiers A.
Patient outcome in the Belgian medical need program on bevacizumab for recurrent glioblastoma.
J Neurol. 2015 Jan 9. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Galldiks N, Dunkl V, Stoffels G, Hutterer M, Rapp M, Sabel M, Reifenberger G, Kebir S, Dorn F, Blau T, Herrlinger U, Hau P, Ruge MI, Kocher M, Goldbrunner R, Fink GR, Drzezga A, Schmidt M, Langen KJ.
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET.
Eur J Nucl Med Mol Imaging. 2014 Nov 20. [Epub ahead of print]

Source | Abstract | Full text | Similar articles




Hacibekiroglu I, Kodaz H, Erdogan B, Turkmen E, Ozcelik M, Esenkaya A, Saygi HM, Uzunoglu S, Cicin I.
Single-agent bevacizumab is an effective treatment in recurrent glioblastoma.
Med Oncol. 2015 Feb;32(2):460. doi: 10.1007/s12032-014-0460-3. Epub 2015 Jan 9.
Source | Abstract | Full text | Similar articles




Jia PF, Gu WT, Zhang WF, Li F.
Treatment of recurrent malignant gliomas with 13-cis-retinoic acid naphthalene triazole.
Neurol Sci. 2015 Jan 6. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Kim HR, Kim KH, Kong DS, Seol HJ, Nam DH, Lim do H, Lee JI.
Outcome of salvage treatment for recurrent glioblastoma.
J Clin Neurosci. 2015 Mar;22(3):468-73. doi: 10.1016/j.jocn.2014.09.018. Epub 2015 Jan 13.
Source | Abstract | Full text | Similar articles




Lee EQ, Reardon DA, Schiff D, Drappatz J, Muzikansky A, Grimm SA, Norden AD, Nayak L, Beroukhim R, Rinne ML, Chi AS, Batchelor TT, Hempfling K, McCluskey C, Smith KH, Gaffey SC, Wrigley B, Ligon KL, Raizer JJ, Wen PY.
Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma.
Neuro Oncol. 2015 Jan 7. pii: nou350. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Levin VA, Mendelssohn ND, Chan J, Stovall MC, Peak SJ, Yee JL, Hui RL, Chen DM.
Impact of bevacizumab administered dose on overall survival of patients with progressive glioblastoma.
J Neurooncol. 2015 Jan 11. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Mallidi S, Watanabe K, Timerman D, Schoenfeld D, Hasan T.
Prediction of tumor recurrence and therapy monitoring using ultrasound-guided photoacoustic imaging.
Theranostics. 2015 Jan 1;5(3):289-301. doi: 10.7150/thno.10155. eCollection 2015.
Source | Abstract | Full text | Similar articles




Niranjan A, Kano H, Iyer A, Kondziolka D, Flickinger JC, Lunsford LD.
Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
J Neurosurg. 2015 Jan 16:1-9. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Pitz MW, Eisenhauer EA, MacNeil MV, Thiessen B, Easaw JC, Macdonald DR, Eisenstat DD, Kakumanu AS, Salim M, Chalchal H, Squire J, Tsao MS, Kamel-Reid S, Banerji S, Tu D, Powers J, Hausman DF, Mason WP.
Phase II study of PX-866 in recurrent glioblastoma.
Neuro Oncol. 2015 Jan 20. pii: nou365. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Rodon J, Carducci MA, Sepulveda-Sánchez JM, Azaro A, Calvo E, Seoane J, Braña I, Sicart E, Gueorguieva I, Cleverly AL, Pillay NS, Desaiah D, Estrem ST, Paz-Ares L, Holdhoff M, Blakeley J, Lahn MM, Baselga J.
First-in-Human Dose Study of the Novel Transforming Growth Factor-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Patients with Advanced Cancer and Glioma.
Clin Cancer Res. 2015 Feb 1;21(3):553-60. doi: 10.1158/1078-0432.CCR-14-1380. Epub 2014 Nov 25.
Source | Abstract | Full text | Similar articles




Wong ET, Lok E, Swanson KD.
Clinical benefit in recurrent glioblastoma from adjuvant NovoTTF-100A and TCCC after temozolomide and bevacizumab failure: a preliminary observation.
Cancer Med. 2015 Jan 26. doi: 10.1002/cam4.421. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Yao CJ, Han TY, Shih PH, Yi TY, Lai IC, Chang KH, Lai TY, Chang CL, Lai GM.
Elimination of cancer stem-like side population in human glioblastoma cells accompanied with stemness gene suppression by Korean herbal recipe MSC500.
Integr Cancer Ther. 2014 Nov;13(6):541-54. doi: 10.1177/1534735414549623. Epub 2014 Oct 29.
Source | Abstract | Full text | Similar articles




Zhong J, Ali AN, Voloschin AD, Liu Y, Curran WJ Jr, Crocker IR, Shu HG.
Bevacizumab-induced hypertension is a predictive marker for improved outcomes in patients with recurrent glioblastoma treated with bevacizumab.
Cancer. 2014 Dec 29. doi: 10.1002/cncr.29234. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





GLIOMAS



Boxerman JL, Ellingson BM, Jeyapalan S, Elinzano H, Harris RJ, Rogg JM, Pope WB, Safran H.
Longitudinal DSC-MRI for Distinguishing Tumor Recurrence From Pseudoprogression in Patients With a High-grade Glioma.
Am J Clin Oncol. 2014 Nov 26. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Han M, Guo L, Zhang Y, Huang B, Chen A, Chen W, Liu X, Sun S, Wang K, Liu A, Li X.
Clinicopathological and Prognostic Significance of CD133 in Glioma Patients: A Meta-Analysis.
Mol Neurobiol. 2015 Jan 15. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Skvortsova TY, Brodskaya ZL, Gurchin AF.
PET using 11C-methionine in recognition of pseudoprogression in cerebral glioma after combined treatment.
Zh Vopr Neirokhir Im N N Burdenko. 2014;78(4):50-8.
Source | Abstract | Full text | Similar articles




BRAIN STEM GLIOMAS


Diffuse intrinsic pontine gliomas


Salloum R, DeWire M, Lane A, Goldman S, Hummel T, Chow L, Miles L, Sutton M, Stevenson C, Fouladi M, Leach J.
Patterns of progression in pediatric patients with high-grade glioma or diffuse intrinsic pontine glioma treated with Bevacizumab-based therapy at diagnosis.
J Neurooncol. 2015 Feb;121(3):591-8. doi: 10.1007/s11060-014-1671-3. Epub 2014 Nov 30.
Source | Abstract | Full text | Similar articles




HIGH-GRADE GLIOMAS


Almenawer SA, Badhiwala JH, Alhazzani W, Greenspoon J, Farrokhyar F, Yarascavitch B, Algird A, Kachur E, Cenic A, Sharieff W, Klurfan P, Gunnarsson T, Ajani O, Reddy K, Singh SK, Murty NK.
Biopsy versus partial versus gross total resection in older patients with high-grade glioma: a systematic review and meta-analysis.
Neuro Oncol. 2015 Jan 3. pii: nou349. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Kim HR, Kim SH, Lee JI, Seol HJ, Nam DH, Kim ST, Park K, Kim JH, Kong DS.
Outcome of radiosurgery for recurrent malignant gliomas: assessment of treatment response using relative cerebral blood volume.
J Neurooncol. 2015 Jan;121(2):311-8. doi: 10.1007/s11060-014-1634-8. Epub 2014 Dec 9.
Source | Abstract | Full text | Similar articles




Zhao X, Bai HX, Zou Y, Yang L.
Reoperation for Recurrent High-Grade Glioma: Does Tumor Genetics Play a Role?
Neurosurgery. 2015 Jan 29. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




LOW-GRADE GLIOMAS


Cappellano AM, Petrilli AS, da Silva NS, Silva FA, Paiva PM, Cavalheiro S, Bouffet E.
Single agent vinorelbine in pediatric patients with progressive optic pathway glioma.
J Neurooncol. 2014 Nov 1. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





MENINGIOMA



Chamberlain MC.
What constitutes activity of systemic therapy in recurrent meningioma?
Neurology. 84(3):280-6. Epub 2015 Feb 17
Source | Abstract | Full text | Similar articles




Iwamoto FM.
Comment: Medical therapy for recurrent or progressive meningiomas remains elusive.
Neurology. 2015 Jan 20;84(3):285. doi: 10.1212/WNL.0000000000001170. Epub 2014 Dec 19.
Source | Abstract | Full text Similar articles




Norden AD, Ligon KL, Hammond SN, Muzikansky A, Reardon DA, Kaley TJ, Batchelor TT, Plotkin SR, Raizer JJ, Wong ET, Drappatz J, Lesser GJ, Haidar S, Beroukhim R, Lee EQ, Doherty L, Lafrankie D, Gaffey SC, Gerard M, Smith KH, McCluskey C, Phuphanich S, Wen PY.
Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.
Neurology. 2015 Jan 20;84(3):280-6. doi: 10.1212/WNL.0000000000001153. Epub 2014 Dec 19.
Source | Abstract | Full text | Similar articles





OLIGODENDROGLIOMA



Yordanova YN, Rodriguez-Arribas MA, Duffau H.
Long-term stabilization by radiosurgery of a secondary focal anaplastic transformation in a surgically treated WHO grade II oligodendroglioma. A case report.
Neurochirurgie. 2015 Jan 14. pii: S0028-3770(14)00284-7. doi: 10.1016/j.neuchi.2014.11.006. [Epub ahead of print]
Source | Abstract | Full text | Similar articles